Q1 2025 USANA Health Sciences Inc Earnings Call

In This Article:

Participants

Andrew Masuda; Director of Investor Relations; Usana Health Sciences Inc

Jim Brown; Chief Executive Officer; USANA Health Sciences Inc

Brent Neidig; Chief Officer and Managing Director of China; USANA Health Sciences Inc

Doug Hekking; Chief Financial Officer; USANA Health Sciences Inc

Walter Noot; Chief Operating Officer; USANA Health Sciences Inc

Anthony Lebiedzinski; Analyst; Sidoti & Company

Ivan Feinseth; Analyst; Tigress Financial Partners

Presentation

Operator

Greetings. Welcome to the USANA Health Sciences first quarter conference call. At this time, all participants are in a listen-only mode. (Operator Instructions)
Please note that this conference is being recorded. I will now turn the conference over to your host, Andrew Masuda, Director of Investor Relations. Thank you. You may begin.

Andrew Masuda

Thank you, Diego, and good morning everyone. We appreciate you joining us to review our first quarter results. Today's conference call is being broadcast live via webcast and can be accessed directly from our website at ir.usana.com. Shortly following the call, a replay will be available on our website.
As a reminder, during the course of this conference call, management will make forward-looking statements regarding future events or the future financial performance of our company. Those statements involve risks and uncertainties that could cause actual results to differ perhaps materially from the results projected in such forward-looking statements.
Examples of these statements include those regarding our strategies and outlook for fiscal year 2025, uncertainty related to the economic and operating environment around the world, and our operations and financial results. We caution you that these statements should be considered in conjunction with disclosures, including specific risk factors and financial data contained in our most recent filings with the SEC.
I'm joined by our President and CEO, Jim Brown; our Chief Financial Officer, Doug Hecking; our Chief Operating Officer, Walter Note; our Chief Commercial Officer, Brett Neidig, as well as other Executives. Yesterday after the market closed, we announced our first quarter results and posted our management commentary document on the company's website. We'll now hear brief remarks from Jim before opening the call for questions.

Jim Brown

Thank you, Andrew, and good morning everyone. USANA is off to a solid start to the year. Our first quarter results were in line with our internal expectations as consolidated net sales grew 12% year over year in constant currency, which includes our first full quarter of contribution from Hiya.
Net sales and active customers in our direct selling business grew modestly on a sequential basis for the second consecutive quarter. While consumer sentiment in some of our key markets continues to reflect an overall cautious tone, we're seeing some pockets of strength. For example, sequential first quarter net sales and active customers in our largest market, mainland China, grew 6% and 4% respectively.
We continue to extricate our associate first strategy that prioritizes associate engagement on multiple levels. Accordingly, we held several leadership events across various markets during the quarter. And have many events planned throughout the remainder of the year. Early in the second quarter, we hosted our China national sales meeting in Nanjing, China. Attendance was strong while we focused on business building, strategy and training, leadership recognition, and USANA's associate first commitment.
We also use this event to broaden our product offering in China with the introduction of additional products. Both attendees and our executive team came away from this event energized and motivated. We also successfully expanded our product offering in several other markets with a rollout of new products during the first quarter.
Simultaneously, the team continued to increase their efforts on several new product launches, that are planned to be announced in the second half of the year. For instance, Dr. Katherine Armstrong, our Chief Scientific Officer, travelled to several of our Asia Pacific markets where she met with Leaders and our local management teams to gather valuable insights and customer feedback as well as collaborate on future product ideas.
Overall, our direct selling business remains on track to meet the sales guidance range we provided at the beginning of the year. Moving to our newly acquired Hiya business, the team continues to deliver robust results with strong growth in net sales and active monthly subscribers. Hiya continues to see increasing subscriber adoption of both its core product offering as well as new products. For example, Kid's Daily Greens, which was launched in the third quarter of 2024, has continued to sell at a higher than expected pace.
We expect this year over year growth and higher momentum to continue as the management team educates its plans to launch several new products this year, unveil another strategic partnership, and expand to additional channels. We're confident in the continued growth of the business and are proud to be reaching a new customer demographic in children's health and wellness.
Before opening the call for questions, I would like to provide some thoughts on USANA's position as it relates to tariffs and other trade-related actions by the US and its trading partners around the world. The impact of potential trade policies and tariffs remain highly uncertain at this time. As such, we have not reflected any potential impact in our financial guidance.
As a reminder, we manufacture in China for our China market and manufacture for the rest of the world here in the US. While this structure does afford some insulation from recently enacted tariffs, we do source certain raw materials from various markets around the globe and therefore have exposure to tariffs.
Our primary focus for now is on the potential tariff impact associated with importing certain raw materials from China into the US and importing certain raw materials from the US into China. Our team responsible for supply chain management has proactively built inventory over the last several quarters to mitigate tariff exposure and has continued to explore alternate source sourcing relationships.
Our team will continue to evaluate and pursue these strategies to address the potential impact of tariffs and emerging trade policies as they evolve. And we plan to provide additional information as we gain greater visibility.
With that, I'll now ask the Operator to please open the lines for questions.